NICE technology appraisal guidance
Issued: April 2009
TA170
Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults
This is an extract from the guidance and may be misleading if read alone. The complete guidance is available at guidance.nice.org.uk/ta170
Important information about this guidance
This guidance was developed using the NICE single technology appraisals process: www.nice.org.uk/aboutnice/howwework/devnicetech/developing_nice_technology_appraisals.jsp